Terms: = Prostate cancer AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1 AND Prognosis
33 results:
1. C-reactive protein levels could be a prognosis predictor of prostate cancer: A meta-analysis.
Zhou K; Li C; Chen T; Zhang X; Ma B
Front Endocrinol (Lausanne); 2023; 14():1111277. PubMed ID: 36817592
[TBL] [Abstract] [Full Text] [Related]
2. Preoperative endogenous testosterone density predicts disease progression from localized impalpable prostate cancer presenting with PSA levels elevated up to 10 ng/mL.
Porcaro AB; Bianchi A; Mazzucato G; Gallina S; Serafin E; Tafuri A; Cerrato C; Panunzio A; Vidiri S; D'Aietti D; Orlando R; Brusa D; Brunelli M; Siracusano S; Cerruto MA; Antonelli A
Int Urol Nephrol; 2023 Jan; 55(1):85-92. PubMed ID: 36197572
[TBL] [Abstract] [Full Text] [Related]
3. The efficacy of cytoreductive surgery for oligometastatic prostate cancer: a meta-analysis.
Cheng B; Ye S; Bai P
World J Surg Oncol; 2021 May; 19(1):160. PubMed ID: 34051809
[TBL] [Abstract] [Full Text] [Related]
4. TRPV2: A cancer Biomarker and Potential Therapeutic Target.
Siveen KS; Nizamuddin PB; Uddin S; Al-Thani M; Frenneaux MP; Janahi IA; Steinhoff M; Azizi F
Dis Markers; 2020; 2020():8892312. PubMed ID: 33376561
[TBL] [Abstract] [Full Text] [Related]
5. Simultaneous Detection of Multiple Tumor Markers in Blood by Functional Liquid Crystal Sensors Assisted with Target-Induced Dissociation of Aptamer.
Qi L; Liu S; Jiang Y; Lin JM; Yu L; Hu Q
Anal Chem; 2020 Mar; 92(5):3867-3873. PubMed ID: 32069024
[TBL] [Abstract] [Full Text] [Related]
6. The TRPV2 cation channels: from urothelial cancer invasiveness to glioblastoma multiforme interactome signature.
Santoni G; Amantini C; Maggi F; Marinelli O; Santoni M; Nabissi M; Morelli MB
Lab Invest; 2020 Feb; 100(2):186-198. PubMed ID: 31653969
[TBL] [Abstract] [Full Text] [Related]
7. Extensive serum cytokine analysis in patients with prostate cancer.
Gong D; Wang Y; Wang Y; Chen X; Chen S; Wang R; Liu L; Duan C; Luo S
Cytokine; 2020 Jan; 125():154810. PubMed ID: 31430659
[TBL] [Abstract] [Full Text] [Related]
8. Buforin IIb induces androgen-independent prostate cancer cells apoptosis though p53 pathway in vitro.
Han Y; Lu M; Zhou J
Toxicon; 2019 Oct; 168():16-21. PubMed ID: 31229626
[TBL] [Abstract] [Full Text] [Related]
9. Matrix metalloproteinase 7, soluble fas and fas ligand serum levels for predicting docetaxel resistance and survival in castration-resistant prostate cancer.
Szarvas T; Sevcenco S; Módos O; Keresztes D; Nyirády P; Csizmarik A; Ristl R; Puhr M; Hoffmann MJ; Niedworok C; Hadaschik B; Maj-Hes A; Shariat SF; Kramer G
BJU Int; 2018 Oct; 122(4):695-704. PubMed ID: 29802777
[TBL] [Abstract] [Full Text] [Related]
10. Galectin-3 Overrides PTRF/Cavin-1 Reduction of PC3 prostate cancer Cell Migration.
Meng F; Joshi B; Nabi IR
PLoS One; 2015; 10(5):e0126056. PubMed ID: 25942420
[TBL] [Abstract] [Full Text] [Related]
11. [Are the properties of peripheral blood lymphocytes of patients with prostate cancer connected with the efficiency of radiation therapy?].
Pelevina II; Aleshchenko AV; Antoshhina MM; Biriukov VA; Kariakin OB; Kudriashova OV; Nikonova MF; Minaeva NG; Serebrianyĭ AM; Iarilin AA
Radiats Biol Radioecol; 2014; 54(3):273-82. PubMed ID: 25764831
[TBL] [Abstract] [Full Text] [Related]
12. Overexpression of long noncoding RNA PCAT-1 is a novel biomarker of poor prognosis in patients with colorectal cancer.
Ge X; Chen Y; Liao X; Liu D; Li F; Ruan H; Jia W
Med Oncol; 2013; 30(2):588. PubMed ID: 23640607
[TBL] [Abstract] [Full Text] [Related]
13. Serological thymidine kinase 1 is a biomarker for early detection of tumours--a health screening study on 35,365 people, using a sensitive chemiluminescent dot blot assay.
Chen ZH; Huang SQ; Wang Y; Yang AZ; Wen J; Xu XH; Chen Y; Chen QB; Wang YH; He E; Zhou J; Skog S
Sensors (Basel); 2011; 11(12):11064-80. PubMed ID: 22247653
[TBL] [Abstract] [Full Text] [Related]
14. PTEN genomic deletions that characterize aggressive prostate cancer originate close to segmental duplications.
Yoshimoto M; Ludkovski O; DeGrace D; Williams JL; Evans A; Sircar K; Bismar TA; Nuin P; Squire JA
Genes Chromosomes Cancer; 2012 Feb; 51(2):149-60. PubMed ID: 22045666
[TBL] [Abstract] [Full Text] [Related]
15. LRIG1 and the liar paradox in prostate cancer: a study of the expression and clinical significance of LRIG1 in prostate cancer.
Thomasson M; Wang B; Hammarsten P; Dahlman A; Persson JL; Josefsson A; Stattin P; Granfors T; Egevad L; Henriksson R; Bergh A; Hedman H
Int J Cancer; 2011 Jun; 128(12):2843-52. PubMed ID: 21128282
[TBL] [Abstract] [Full Text] [Related]
16. [Serum cytokine profiling of prostate cancer and benign prostatic hyperplasia using recombinant antibody microarray].
Zhang L; Sun SK; Shi LX; Zhang X
Zhonghua Nan Ke Xue; 2010 Jul; 16(7):584-8. PubMed ID: 20873589
[TBL] [Abstract] [Full Text] [Related]
17. Imaging mass spectrometry of a specific fragment of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 2 discriminates cancer from uninvolved prostate tissue.
Cazares LH; Troyer D; Mendrinos S; Lance RA; Nyalwidhe JO; Beydoun HA; Clements MA; Drake RR; Semmes OJ
Clin Cancer Res; 2009 Sep; 15(17):5541-51. PubMed ID: 19690195
[TBL] [Abstract] [Full Text] [Related]
18. Fatty acid synthase and cancer: new application of an old pathway.
Kuhajda FP
Cancer Res; 2006 Jun; 66(12):5977-80. PubMed ID: 16778164
[TBL] [Abstract] [Full Text] [Related]
19. Inhibition of the phosphatidylinositol 3'-kinase pathway promotes autocrine fas-induced death of phosphatase and tensin homologue-deficient prostate cancer cells.
Bertram J; Peacock JW; Tan C; Mui AL; Chung SW; Gleave ME; Dedhar S; Cox ME; Ong CJ
Cancer Res; 2006 May; 66(9):4781-8. PubMed ID: 16651432
[TBL] [Abstract] [Full Text] [Related]
20. High-level expression of fatty acid synthase in human prostate cancer tissues is linked to activation and nuclear localization of Akt/PKB.
Van de Sande T; Roskams T; Lerut E; Joniau S; Van Poppel H; Verhoeven G; Swinnen JV
J Pathol; 2005 Jun; 206(2):214-9. PubMed ID: 15880754
[TBL] [Abstract] [Full Text] [Related]
[Next]
